Lacrimal Gland Cells, situated within the orbit of the eye, are instrumental in the production and secretion of tears, contributing to ocular surface health and visual comfort. Comprising both acinar and ductal cells, these glands produce a complex fluid containing water, electrolytes, proteins, and mucins, collectively forming the tear film. Acinar cells synthesize and release the aqueous component of tears, while ductal cells modify the composition by adding electrolytes. The tear film serves multiple functions, including lubrication, protection against microbial invasion, and maintenance of optical clarity. Lacrimal gland cells are regulated by neural and hormonal signals; sympathetic stimulation increases tear production, while parasympathetic activity promotes mucin secretion. Dysfunction of lacrimal gland cells can lead to dry eye syndrome, a common condition characterized by inadequate tear production. Autoimmune disorders, medications, or environmental factors may contribute to lacrimal gland dysfunction. Understanding the physiology of these cells is crucial for developing treatments for dry eye and other ocular surface disorders. Ongoing research explores innovative therapeutic approaches, including artificial tears, anti-inflammatory agents, and glandular stimulation, to enhance tear film function and alleviate ocular discomfort.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States